Net Income (Loss) Attributable to Parent in USD of FIBROGEN INC from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Fibrogen Inc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2013 to Q3 2025.
  • Fibrogen Inc Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $201M.
  • Fibrogen Inc Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $216M.
  • Fibrogen Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$47.6M, a 83.3% increase from 2023.
  • Fibrogen Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$284M, a 3.21% increase from 2022.
  • Fibrogen Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$294M, a 1.25% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

FIBROGEN INC Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $216M $201M +$218M 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$2.07M -$7.6M +$7.94M +51.1% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 -$10M $4.64M +$37.6M 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 -$47.6M $18M +$74.2M 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025
Q3 2024 -$122M -$17.1M +$46.5M +73.1% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$168M -$15.5M +$72.1M +82.3% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 -$240M -$32.9M +$43.8M +57.1% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 -$284M -$56.2M +$9.94M +15% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025
Q3 2023 -$294M -$63.6M +$28M +30.6% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$322M -$87.7M -$15.1M -20.7% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 -$307M -$76.7M -$13.5M -21.4% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 -$294M -$66.2M +$67.9M +50.6% 01 Oct 2022 31 Dec 2022 10-K 26 Feb 2024
Q3 2022 -$362M -$91.7M -$141M -284% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 -$220M -$72.6M +$61.4M +45.8% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 -$281M -$63.2M +$8.55M +11.9% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 -$290M -$134M -$75.4M -129% 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024
Q3 2021 -$215M $49.8M +$16.8M +50.9% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$231M -$134M -$48.7M -57.1% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$183M -$71.8M +$6.59M +8.42% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$189M -$58.6M +$39.5M +40.2% 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023
Q3 2020 -$229M $33M +$82.4M 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$311M -$85.3M -$201M -174% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 -$110M -$78.3M -$32.9M -72.5% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 -$77M -$98.1M -$119M -568% 01 Oct 2019 31 Dec 2019 10-K/A 04 Mar 2022
Q3 2019 $42.1M -$49.4M -$6.88M -16.2% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 $49M $116M +$139M 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 -$90.4M -$45.4M -$4.02M -9.7% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 -$86.4M $21M +$54.8M 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021
Q3 2018 -$141M -$42.6M -$18.1M -74% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$123M -$23.4M +$8.49M +26.6% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 -$132M -$41.4M -$10.8M -35.2% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 -$121M -$33.9M -$3.51M -11.5% 01 Oct 2017 31 Dec 2017 10-K 02 Mar 2020
Q3 2017 -$117M -$24.5M -$305K -1.26% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 -$117M -$31.9M -$56.2M -231% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018
Q1 2017 -$60.8M -$30.6M -$2.77M -9.95% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 -$58.1M -$30.4M +$21M +40.8% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019
Q3 2016 -$79M -$24.2M +$20.9M +46.4% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017
Q2 2016 -$100M $24.3M -$32.7M -57.4% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 -$67.3M -$27.8M +$18.5M +40% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q4 2015 -$85.8M -$51.4M -$809K -1.6% 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018
Q3 2015 -$85M -$45.1M -$5.56M -14.1% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016
Q2 2015 -$79.4M $57.1M +$10.2M +21.8% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016
Q1 2015 -$89.6M -$46.4M -$30.1M -186% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q4 2014 -$59.5M -$50.6M 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017
Q3 2014 -$39.5M 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 $46.8M 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015
Q1 2014 -$16.2M 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015

FIBROGEN INC Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$47.6M +$237M +83.3% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025
2023 -$284M +$9.42M +3.21% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025
2022 -$294M -$3.63M -1.25% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2024
2021 -$290M -$101M -53.2% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024
2020 -$189M -$112M -146% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023
2019 -$77M +$9.45M +10.9% 01 Jan 2019 31 Dec 2019 10-K/A 04 Mar 2022
2018 -$86.4M +$34.5M +28.5% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 -$121M -$62.8M -108% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020
2016 -$58.1M +$27.7M +32.3% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 -$85.8M -$26.3M -44.2% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
2014 -$59.5M -$44.6M -298% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017
2013 -$14.9M 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.